Arginase inhibitors and methods of use
US12215116B2 · kind B2 · utility
0Cited by
3References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2019 |
| Grant date | Feb 4, 2025 |
| Priority date | — |
| Expiry date | Nov 17, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2818
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.